These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 14624474)
1. Increased insulin-like growth factor-I gene expression precedes left ventricular cardiomyocyte hypertrophy in a rapidly-hypertrophying rat model system. Huang CY; Buchanan DL; Gordon RL; Sherman MJ; Razzaq J; White K; Buetow DE Cell Biochem Funct; 2003 Dec; 21(4):355-61. PubMed ID: 14624474 [TBL] [Abstract][Full Text] [Related]
2. Selective increase in cardiac IGF-1 in a rat model of ventricular hypertrophy. Ebensperger R; Acevedo E; Meléndez J; Corbalán R; Acevedo M; Sapag-Hagar M; Jalil JE; Lavandero S Biochem Biophys Res Commun; 1998 Feb; 243(1):20-4. PubMed ID: 9473472 [TBL] [Abstract][Full Text] [Related]
3. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I. Donohue TJ; Dworkin LD; Ma J; Lango MN; Catanese VM J Investig Med; 1997 Dec; 45(9):584-91. PubMed ID: 9444886 [TBL] [Abstract][Full Text] [Related]
5. The profile of cardiac cytochrome c oxidase (COX) expression in an accelerated cardiac-hypertrophy model. Kuo WW; Chu CY; Wu CH; Lin JA; Liu JY; Ying TH; Lee SD; Hsieh YH; Chu CH; Lin DY; Hsu HH; Huang CY J Biomed Sci; 2005; 12(4):601-10. PubMed ID: 16132109 [TBL] [Abstract][Full Text] [Related]
6. Development of smooth muscle hypertrophy is closely associated with increased gene expression of insulin-like growth factor binding protein-2 and -4. Chen Y; Arner A; Bornfeldt KE; Uvelius B; Arnqvist HJ Growth Regul; 1995 Mar; 5(1):45-52. PubMed ID: 7538370 [TBL] [Abstract][Full Text] [Related]
7. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Donohue TJ; Dworkin LD; Lango MN; Fliegner K; Lango RP; Benstein JA; Slater WR; Catanese VM Circulation; 1994 Feb; 89(2):799-809. PubMed ID: 8313569 [TBL] [Abstract][Full Text] [Related]
8. Effect of metabolic acidosis on the insulin-like growth factor-I system and cathepsins B and L gene expression in the kidney. Fawcett J; Hsu FW; Tsao T; Rabkin R J Lab Clin Med; 2000 Dec; 136(6):468-75. PubMed ID: 11128748 [TBL] [Abstract][Full Text] [Related]
9. Increased insulin-like growth factor-1 protein in human left ventricular hypertrophy. Pauliks LB; Cole KE; Mergner WJ Exp Mol Pathol; 1999 Apr; 66(1):53-8. PubMed ID: 10331964 [TBL] [Abstract][Full Text] [Related]
10. In vivo protein synthetic rates of atrial, ventricular, and pulmonary tissue proteins in aortic constriction, goldblatt, and bromoethylamine models of hypertension. Siddiq T; Patel VB; Sherwood R; Richardson PJ; Preedy VR Exp Mol Pathol; 2001 Feb; 70(1):19-30. PubMed ID: 11170787 [TBL] [Abstract][Full Text] [Related]
11. Impaired IGF-I signalling of hypertrophic hearts in the developmental phase of hypertension in genetically hypertensive rats. Kuo WW; Chu CY; Wu CH; Lin JA; Liu JY; Hsieh YH; Ueng KC; Lee SD; Hsieh DJ; Hsu HH; Chen LM; Huang CY Cell Biochem Funct; 2005; 23(5):325-31. PubMed ID: 15996002 [TBL] [Abstract][Full Text] [Related]
12. Serum from patients with chronic renal insufficiency alters growth characteristics and ANP mRNA expression of adult rat cardiac myocytes. Yu JZ; Bondy GP; Allard MF; Thompson CR; Levin A; McManus BM J Mol Cell Cardiol; 1996 Dec; 28(12):2429-41. PubMed ID: 9004160 [TBL] [Abstract][Full Text] [Related]
13. [Effect of astragalus on calcium accumulation and SERCA2a gene expression in myocardial tissues in rats with pressure overload-induced left ventricular hypertrophy]. Su D; Xu B; Shi HL; Wu DZ; Dai YL Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(14):1724-7. PubMed ID: 18841778 [TBL] [Abstract][Full Text] [Related]
14. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function. Gao S; Long CL; Wang RH; Wang H Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734 [TBL] [Abstract][Full Text] [Related]
15. Effect of long-term heart rate reduction by If current inhibition on pressure overload-induced heart failure in rats. Ciobotaru V; Heimburger M; Louedec L; Heymes C; Ventura-Clapier R; Bedossa P; Escoubet B; Michel JB; Mercadier JJ; Logeart D J Pharmacol Exp Ther; 2008 Jan; 324(1):43-9. PubMed ID: 17901295 [TBL] [Abstract][Full Text] [Related]
16. Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle. Brattelid T; Qvigstad E; Birkeland JA; Swift F; Bekkevold SV; Krobert KA; Sejersted OM; Skomedal T; Osnes JB; Levy FO; Sjaastad I J Mol Cell Cardiol; 2007 Dec; 43(6):767-79. PubMed ID: 17936780 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone, acromegaly, and heart failure: an intricate triangulation. Saccà L; Napoli R; Cittadini A Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906 [TBL] [Abstract][Full Text] [Related]
18. Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats. Bhuiyan MS; Shioda N; Fukunaga K Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1606-14. PubMed ID: 17878225 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis in pressure overload-induced cardiac hypertrophy is mediated, in part, by adenine nucleotide translocator-1. Hang T; Huang Z; Jiang S; Gong J; Wang C; Xie D; Ren H Ann Clin Lab Sci; 2006; 36(1):88-95. PubMed ID: 16501242 [TBL] [Abstract][Full Text] [Related]
20. The possible role of caspase-3 in pathological and physiological cardiac hypertrophy in rats. Balakumar P; Singh M Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):418-24. PubMed ID: 17169122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]